Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 86 (4) , 377-381
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Performance of the New Version (v2.0) of the GenoType MTBDR sl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex StrainsJournal of Clinical Microbiology, 2016
- Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2015
- New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB MutationsPLOS ONE, 2012
- The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow regionJournal of Antimicrobial Chemotherapy, 2012
- Detection of Resistance to Second-Line Antituberculosis Drugs by Use of the Genotype MTBDR sl Assay: a Multicenter Evaluation and Feasibility StudyJournal of Clinical Microbiology, 2012
- Characterization of Mutations Conferring Extensive Drug Resistance to Mycobacterium tuberculosis Isolates in PakistanAntimicrobial Agents and Chemotherapy, 2011
- Molecular Characterization of Fluoroquinolone Resistance inMycobacterium tuberculosis: Functional Analysis ofgyrAMutation at Position 74Antimicrobial Agents and Chemotherapy, 2011
- High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs GeneAntimicrobial Agents and Chemotherapy, 2009
- Feasibility of the GenoType MTBDR sl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical SpecimensJournal of Clinical Microbiology, 2009
- Discordant Resistance to Kanamycin and Amikacin in Drug-Resistant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2003